INDOUS vs PKTEA: Stock Comparison
PKTEA is the larger company by market capitalisation. INDO US BIOTECH shows a higher ROE, a higher ROCE and a higher net margin, while PKTEA shows faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
INDOUS leads 5; PKTEA leads 3 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDOUS | PKTEA |
|---|---|---|
| Sector | Fast Moving Consumer Goods | Fast Moving Consumer Goods |
| Industry | Other Agricultural Products | Tea & Coffee |
Price
| Metric | INDOUS | PKTEA |
|---|---|---|
| Live Price | ₹65.34 | ₹921.25 |
| Day Change | -1.85% | -1.68% |
| Volume | 4,878 | 2,604 |
| 52-Week High | ₹159 | ₹1,169 |
| 52-Week Low | ₹57.5 | ₹605 |
| Distance from 52W High | -58.91% | -21.19% |
Valuation
| Metric | INDOUS | PKTEA |
|---|---|---|
| Market Cap | ₹134 Cr | ₹222 Cr |
| P/E Ratio | 0x | 0x |
| P/B Ratio | 0x | 0x |
| EPS | ₹1,69,098.66 | ₹11.9 |
| Book Value | ₹63.54 | ₹1,452.01 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | INDOUS | PKTEA |
|---|---|---|
| Revenue Growth (TTM YoY) | -22% | 31.1% |
| EPS Growth (TTM YoY) | -47.3% | 0% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | INDOUS | PKTEA |
|---|---|---|
| ROE | 14.18% | -1.48% |
| ROCE | 10.86% | 0.2% |
| Net Margin | 11.88% | -11.72% |
| Operating Margin | 14.64% | 1.42% |
| Debt to Equity | 0.4x | 0.1x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | INDOUS | PKTEA |
|---|---|---|
| Promoter Holding | 68.29% | 67.66%▲ 1.33 pp |
| FII Holding | 0.01% | 0% |
| DII Holding | 0.25%▲ 0.25 pp | 1.66%▼ 1.75 pp |
| Public Holding | 31.45%▼ 0.25 pp | 30.09%▲ 0.43 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INDO US BIOTECH and PKTEA.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.